Pediatric rheumatology

Epidemiology of Kawasaki Disease After the COVID-19 Pandemic in Japan 2023-2024

JAMA Netw OpenPublished Cohort study

Authors' conclusion

In this nationwide cohort study of KD in Japan, KD incidence rebounded after the relaxation of COVID-19 pandemic-related restrictions, with age-dependent patterns.

Study context

Population
Patients with Kawasaki disease (KD) in the Japanese Nationwide Survey of Kawasaki Disease 2023–2024, plus historical survey data 1975 through 2024467,456 in 1975–2024 trend analysis
Participants
29,841 patients
Exposure
Infants vs 1 to 4 years vs 5 to 9 years
Outcome
Annual KD incidence overall and stratified by 3 age groups: infants (<1 year), 1 to 4 years, and 5 to 9 years
Methodological detailsdescriptive epidemiologic analysis, nationwide survey, 50 years of historical data
  • Descriptive epidemiologic analysis
  • Nationwide survey
  • 50 years of historical data

Main finding

As reported in the abstract

Annual KD incidence
Patients registered in 2023
15 032
Patients registered in 2024
14 809
Increase in KD incidence rates across the 50-year period, despite a 61.6% decline in the population under 5 years
16.1-fold
Patient-number nadir in 2022
10 333
Rebound to 15 032 cases in 2023 (increase)
45.5%
Indexed incidence (2017 = 100), 5 to 9 years: largest decline, nadir in 2021 (45.8% below baseline)
54.2
Indexed incidence (2017 = 100), 5 to 9 years: largest rebound in 2024 (34.8% above baseline)
134.8
Indexed incidence (2017 = 100), <1 year: smallest decline, nadir; did not return to baseline
73
Magnitude of rebound, infants
26.1%
Magnitude of rebound, aged 1 year
38.9%
Magnitude of rebound, aged 2 years
42.7%
Magnitude of rebound, aged 3 years
85.8%
Magnitude of rebound, aged 4 years
105.3%
Magnitude of rebound, aged 5 to 9 years
166.7%

Observational data: associations, not effects.

Original publication

Epidemiology of Kawasaki Disease After the COVID-19 Pandemic in Japan 2023-2024. JAMA Netw Open. Published 3 August 2026. doi:10.1001/jamanetworkopen.2026.26910

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.